Evidence map›Paper›PMID 28264824›Full record

Trial reportBMJ open2017

Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study.

Anne M May, Marcel J C Bosch, Miranda J Velthuis, Elsken van der Wall, Charlotte N Steins Bisschop, Maartje Los, Frans Erdkamp, Haiko J Bloemendal, Marnix A J de Roos, Marlies Verhaar and 3 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 10 pooled it
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 10 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A Systematic Literature Review of Health Utility Values in Breast Cancer.Medical decision making : an international journal of the Society for Medical Decision Making · 2022
    Pooled it
  5. Effectiveness of exercise training on cancer-related fatigue in colorectal cancer survivors: a systematic review and meta-analysis of randomized controlled trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Anne M MayUniversity Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
Marcel J C BoschUniversity Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
Miranda J VelthuisNetherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Elsken van der WallUniversity Medical Center Utrecht, Cancer Center, Utrecht, The Netherlands.
Charlotte N Steins BisschopUniversity Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
Maartje LosDepartment of Medical Oncology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Frans ErdkampDepartment of Internal Medicine-Medical Oncology, Orbis Medical Center, Sittard-Geleen, The Netherlands.
Haiko J BloemendalDepartment of Internal Medicine, Medical Center Amersfoort, Amersfoort, The Netherlands.
Marnix A J de RoosDepartment of Surgery, Hospital Rivierenland, Tiel, The Netherlands.
Marlies VerhaarDepartment of Internal Medicine, Hofpoort Hospital, Woerden, The Netherlands.
Daan Ten Bokkel HuininkDepartment of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands.
Petra H M PeetersUniversity Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
G Ardine de WitUniversity Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
University Medical Center Utrecht · NLDiakonessenhuis hospital · NLNetherlands Comprehensive Cancer Organisation · NLSt. Antonius Ziekenhuis · NLZiekenhuis Rivierenland · NLZuyderland Medisch Centrum · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMeta-analyses show that exercise interventions during cancer treatment reduce cancer-related fatigue. However, little is known about the cost-effectiveness of such interventions. Here we aim to assess the cost-effectiveness of the 18-week physical activity during cancer treatment (PACT) intervention for patients with breast and colon cancer. The PACT trial showed beneficial effects for fatigue and physical fitness.

designCost-effectiveness analyses with a 9-month time horizon (18 weeks of intervention and 18 weeks of follow-up) within the randomised controlled multicentre PACT study.

settingOutpatient clinics of 7 hospitals in the Netherlands (1 academic and 6 general hospitals)

participants204 patients with breast cancer and 33 with colon cancer undergoing adjuvant treatment including chemotherapy.

interventionSupervised 1-hour aerobic and resistance exercise (twice per week for 18 weeks) or usual care.

main outcome measuresCosts, quality-adjusted life years (QALY) and the incremental cost-effectiveness ratio.

resultsFor colon cancer, the cost-effectiveness analysis showed beneficial effects of the exercise intervention with incremental costs savings of €4321 and QALY improvements of 0.03. 100% of bootstrap simulations indicated that the intervention is dominant (ie, cheaper and more effective). For breast cancer, the results did not indicate that the exercise intervention was cost-effective. Incremental costs were €2912, and the incremental effect was 0.01 QALY. At a Dutch threshold value of €20 000 per QALY, the probability that the intervention is cost-effective was 2%.

conclusionsOur results suggest that the 18-week exercise programme was cost-effective for colon cancer, but not for breast cancer. TRIAL REGISTRATION NUMBER: ISRCTN43801571.

Indexed as

Breast NeoplasmsChemotherapy, AdjuvantColonic NeoplasmsCost-Benefit AnalysisExercise TherapyFemaleHumansMaleMiddle AgedNetherlandsProgram EvaluationTreatment Outcomeadjuvant treatmentbreast cancercolon cancercoste-effectivenessexercise interventionquality of life

Identifiers

PMID28264824
PMCPMC5353266
OpenAlexW2594643477

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.